Nurse Practitioner, Gerontology · Houston, TX
NPI
1366208894
Since 2024
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
273 services
Medicare patients, 2024
197
Average age 74
Drug cost, 2024
$1.3M
401 prescriptions
Company payments, 2025
$2,164
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katherine E Graap was code 99213 (office e&m - established), 163 times for 115 patients. In total Katherine E Graap billed 273 services in 9 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 163 | 115 | $44.53 | $7,259 |
| 38222 Other Organ Systems | Facility | 53 | 53 | $50.82 | $2,693 |
| 99441 Telephone Services | Facility | 29 | 26 | $23.64 | $686 |
Medicare prescription drug claims, 2024
In 2024, the drug Katherine E Graap prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 67 prescriptions and refills. In total Katherine E Graap wrote 401 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 67 | 111 | 25 | $2,631 |
| Inqovi Decitabine/Cedazuridine | 33 | 33 | Under 11 | $251K |
| Levofloxacin Generic | 32 | 40 | 16 | $319 |
| Jakafi Ruxolitinib Phosphate | 20 | 20 | Under 11 | $328K |
| Voriconazole Generic | 19 | 25 | Under 11 | $13K |
| Allopurinol Generic | 17 | 33 | Under 11 | $149 |
| Bosulif Bosutinib | 14 | 14 | Under 11 | $139K |
| Potassium Chloride Generic | 12 | 12 | Under 11 | $208 |
| Hydroxyurea Generic | 12 | 18 | Under 11 | $300 |
| Venclexta Venetoclax | 11 | 11 | Under 11 | $52K |
Brand drugs: 130 claims; generic drugs: 271 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katherine E Graap $2,164 ($2,164 in general payments such as food, travel and fees) from 15 companies. The largest payer was Astellas Pharma US Inc with $348.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 6 | $348 |
| Syndax Pharmaceuticals, Inc. SNDX | 5 | $345 |
| GlaxoSmithKline, LLC. GSK | 8 | $329 |
| Sobi, Inc SOBI.ST | 6 | $272 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $258 |
| Abbvie Inc. ABBV | 3 | $236 |
| Lilly USA, LLC LLY | 2 | $86.9 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $78.75 |
| Celgene Corporation BMY | 2 | $52.5 |
| Teleflex LLC TFX | 1 | $29.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.